Otsuka Holdings Co Limited (PK) News - OTSKY

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)

333-184441 SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Abilify Maker Otsuka to Buy Avanir for $3.5 Billion

By Atsuko Fukase And Eric Pfanner TOKYO--Otsuka Pharmaceutical Co. agreed to buy Avanir Pharmaceuticals Inc. of the U.S. for $3.5 billion, the...

Otsuka to Buy Avanir for $3.5 Billion

Japanese drug maker Otsuka Pharmaceutical Co. has agreed to buy California-based Avanir Pharmaceuticals Inc. in a deal that values the...

Securities Registration (ads, Immediate) (f-6ef)

As filed with the Securities and Exchange Commission on October 16, 2014 Registration No...

Securities Registration (ads, Immediate) (f-6ef)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

Supreme Court Rejects Generic Challenge to Otsuka's Abilify Patent

WASHINGTON--The U.S. Supreme Court on Monday refused to consider a generic drug maker's challenge to Otsuka Pharmaceutical Co.'s U.S. patent for...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Otsuka Holdings Co Limited (PK) (OTSKY)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

OTSKY News

Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)

Abilify Maker Otsuka to Buy Avanir for $3.5 Billion

Otsuka to Buy Avanir for $3.5 Billion

Securities Registration (ads, Immediate) (f-6ef)

Securities Registration (ads, Immediate) (f-6ef)

Supreme Court Rejects Generic Challenge to Otsuka's Abilify Patent

OTSKY Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Otsuka Holdings Co Limited (PK) (OTSKY) News

Otsuka Holdings Co Limited (PK) (OTSKY)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

OTSKY News

Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)

Abilify Maker Otsuka to Buy Avanir for $3.5 Billion

Otsuka to Buy Avanir for $3.5 Billion

Securities Registration (ads, Immediate) (f-6ef)

Securities Registration (ads, Immediate) (f-6ef)

Supreme Court Rejects Generic Challenge to Otsuka's Abilify Patent

OTSKY Discussion

Your Recent History